Publikationen 2016

1. Mueller T, Gegenhuber A, Leitner I, Poelz W, Haltmayer M, Dieplinger B. Diagnostic and prognostic accuracy of galectin-3 and soluble ST2 for acute heart failure. Clin Chim Acta 2016;463:158-64. [PubMed

2. Mueller T, Dieplinger B. Soluble ST2 and Galectin-3: What we know and don't know analytically. EJIFCC 2016;27:224-37. [PubMed

3. Natriuretic Peptides Studies Collaboration. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis. Lancet Diabetes Endocrinol 2016;4:840-9. [PubMed]   

4. Dieplinger B, Egger M, Leitner I, Firlinger F, Poelz W, Lenz K, Haltmayer M, Mueller T. Interleukin-6, galectin-3, GDF-15, and soluble ST2 for mortality prediction in critically ill patients. J Crit Care 2016;34:38-45. [PubMed]  

5. Zimmermann M, Traxler D, Simader E, Bekos C, Dieplinger B, Lainscak M, Ankersmit HJ, Mueller T. In vitro stability of heat shock protein 27 in serum and plasma under different preanalytical conditions: implications for large-scale clinical studies. Ann Lab Med 2016;36:353-7. [PubMed]  

6. Mueller T, Hinterreiter F, Poelz W, Haltmayer M, Dieplinger B. Mortality rates at ten years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease. Vasc Med 2016;21:445-52.  [PubMed]

7. Mueller T, Egger M, Leitner I, Gabriel C, Haltmayer M, Dieplinger B. Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors. Clin Chim Acta 2016;456:19–23. [PubMed]